TOCEM Interim Analysis
Just Published in Radiology
Addition of Contrast-enhanced Mammography to Tomosynthesis for Breast Cancer Detection in Women with a Personal History of Breast Cancer: Prospective TOCEM Trial Interim Analysis. Women with a personal history of breast cancer are at higher risk for second cancers and for having that cancer missed on mammography. Interim analysis from the ongoing TOCEM study, led by DBI Chief Scientific Advisor Dr. Berg, shows very favorable results using annual screening contrast-enhanced mammography (CEM) after tomosynthesis, with added cancer yield of 7/1000 in year 1 and 4/1000 in years 2 and 3, small median invasive tumor size of 0.6 cm, mostly node negative. Added recalls occurred in 6.6% women year 1 and 5% in subsequent years.